Gonçalves, Laura Sanches
Melo, Stéffany Souza
de Oliveira, Guilherme José Pimentel Lopes
Figueiredo, Luciene Cristina
Bezerra, Fabio José Barbosa
Furlaneto, Flávia Aparecida Chaves
de Souza, Sérgio Luís Scombatti
Funding for this research was provided by:
Universidade De São Paulo
Article History
Received: 15 August 2025
Accepted: 12 February 2026
First Online: 24 February 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the institution’s Human Research Ethics Committee (protocol number 60530022.1.0000.5419). Furthermore, the study was registered in the Brazilian Clinical Trials Registry (ReBEC - number RBR-475mc4q).
: Written informed consent was obtained from all participants prior to their inclusion in the study.
: Fabio Jose Barbosa Bezerra is the Chief Executive Officer (CEO) of New Dental Care, a company that operates in the oral care industry. This professional position is unrelated to the conduct of the research described in the manuscript; however, it is disclosed here in the interest of full transparency.All other authors have no conflict of interest.